Trim INTC 30% to 52x P/E and hostile macro; hard stop at $94; re-enter on pullback to $85-90 or breakout above $120
Underweight INTC on valuation and macro concerns while retaining residual exposure given intact operating inflection (Q2 results, CEO insider buying). Trimexecution is tranched to avoid committing into overhead supply before rejection. Hard stop at $94 provides proper ATR room (~2.2x ATR) for a beta 2.23 name. No hedge overlay per binding lesson on trim-with-decay inefficiency.
| Position | Action |
|---|---|
| General position reduction | Trim ~30% of INTC exposure |
| Tranche 1 execution | 15% trim at market near $106 |
| Tranche 2 execution (only if overhead supply rejects) | 15% via limit at $108-112 |
Intel is in a verifiable operational turnaround with accelerating revenue growth, dramatic margin expansion, positive FCF inflection, and technicals confirming bullish momentum continuation—not a momentum fantasy but a fundamental business transformation.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 96.31 | neutral |
| close_50_sma | 99.62 | bearish |
| close_200_sma | 74.86 | bullish |
| RSI(14) | 63.36 | bullish |
| MACD | -0.19 | bullish |
| MACD_Signal | -2.21 | bullish |
| MACD_Histogram | +2.01 | bullish |
| boll_mid | 94.72 | neutral |
| boll_upper | 107.81 | neutral |
| boll_lower | 81.63 | neutral |
| ATR(14) | 5.37 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed breakout and hold above $120 with volume >100M AND macro easing signal
Then: Re-enter residual exposure
The trailing EPS distortion is due to one-time non-operating loss, not operational failure; forward earnings are strong
EV: $115-120
Intel's stock has already priced in operational improvements at a demanding 52x forward P/E after a 300% YTD run, leaving the risk/reward asymmetric to the downside given stagflation macro risks, declining technical overhead, intensifying foundry competition from Amkor/TSMC/NVIDIA's $12B Arizona bet, and a balance sheet that consumed 23% of shareholder equity in six months.
· concedes: Revenue is up — operational improvement is real; Gross margins are expanding; FCF turned positive; All true, all already priced in
→ vs neutral: MACD bullish crossover and RSI at 63 are not evidence of upside—momentum flips constructive after 25% corrections all the time; RSI recovering from 31 to 63 in six weeks is textbook dead-cat bounce into overhead supply
→ vs neutral: $107.81 breakout above Bollinger upper band represents overhead supply to sell into, not a launching pad for new longs
→ vs conservative: Revenue up 25% YoY, 1,290 bps gross margin expansion, FCF from negative $1.5B to positive $4.45B are impressive but already priced in at 52x; requires SUPER-execution to justify multiple
→ vs conservative: Macro factors (WTI above $101, 93% Polymarket odds of zero Fed cuts, rising yields) are not 'noise'—they represent regime change crushing long-duration assets
→ vs conservative: Apple actively engineering Intel out of macOS is structural erosion, not a cyclical wobble
→ vs neutral: Competitive landscape (NVDA, QCOM, AMD, Amkor) are 'four independent vectors of structural pressure,' not just headwinds to monitor
| VWMA(20) | 92.81 | bullish |
Support: 99.62 · 96.31 · 94.72 · 89 · 81.63 · 74.86 | Resistance: 107.81 · 110 · 112
INTC exhibits a bullish stack formation with price ($106.24) above all major moving averages (10 EMA 96.31, 50 SMA 99.62, 200 SMA 74.86), though the 50 SMA remains declining at $99.62 creating dynamic resistance. RSI of 63.36 indicates room for further upside before overbought conditions (70 threshold), rising from a recent low of 31.49 on 2026-07-29. MACD shows bullish momentum with histogram at +2.01 (positive and expanding) and the MACD line at -0.19 approaching a bullish crossover above the signal line at -2.21. Bollinger bandwidth of $26.18 signals elevated volatility, with price currently testing the upper band at $107.81; a confirmed break above would be a high-conviction long trigger. ATR has compressed to 5.37 from a panic peak of 9.57, suggesting daily ranges of $5-7 are realistic. Volume confirmed the recent breakout with 140.3M on 2026-09-08 being the highest volume day in the recent rebound window. The final recommendation is HOLD with bias to add on confirmed breakout above $107.81, using $96.31 (10 EMA) as stop-loss for new entries.
Market Cap
$561.60B
Forward P/E
52.01x
PEG Ratio
1.36
Price/Book
6.12x
EPS (TTM)
-$2.09
Forward EPS
$2.04
52-Week High
$142.35
52-Week Low
$24.05
50-Day Avg
$100.13
200-Day Avg
$74.51
Book Value/Share
$17.36
Beta
2.231
Gross Margin
~38.9%
Operating Margin
12.2%
Profit Margin
-19.8%
EBITDA Margin
~29.5%
Return on Equity
-10.7%
Return on Assets
+1.4%
FCF (TTM)
$4.87B
Cash + ST Investments
$29.73B
Current Ratio
1.60x
Net Debt
$37.66B
Total Assets
$202.44B
Total Equity
$87.54B
Total Debt
$50.54B
Working Capital
$21.54B
Net PPE
$105.74B
Inventory
$12.49B
Minority Interest
$15.6B
Revenue (Q2 2025)
$12.86B
Gross Profit (Q2 2025)
$3.54B
Operating Income (Q2 2025)
-$1.29B
Net Income (Q2 2025)
-$2.92B
Diluted EPS (Q2 2025)
-$0.67
Revenue (Q3 2025)
$13.65B
Gross Profit (Q3 2025)
$5.22B
Operating Income (Q3 2025)
$0.86B
Net Income (Q3 2025)
$4.27B
Diluted EPS (Q3 2025)
$0.90
Revenue (Q4 2025)
$13.67B
Gross Profit (Q4 2025)
$4.94B
Operating Income (Q4 2025)
$0.55B
Net Income (Q4 2025)
-$0.33B
Diluted EPS (Q4 2025)
-$0.12
Revenue (Q1 2026)
$13.58B
Gross Profit (Q1 2026)
$5.35B
Operating Income (Q1 2026)
$0.93B
Net Income (Q1 2026)
-$4.28B
Diluted EPS (Q1 2026)
-$0.73
Revenue (Q2 2026)
$16.13B
Gross Profit (Q2 2026)
$6.51B
Operating Income (Q2 2026)
$1.97B
Net Income (Q2 2026)
-$11.03B
Diluted EPS (Q2 2026)
-$2.16
Operating CF (Q2 2025)
$2.05B
CapEx (Q2 2025)
-$3.55B
Free Cash Flow (Q2 2025)
-$1.50B
Net Debt Issuance (Q2 2025)
+$0.49B
Operating CF (Q3 2025)
$2.55B
CapEx (Q3 2025)
-$2.43B
Free Cash Flow (Q3 2025)
$0.12B
Net Debt Issuance (Q3 2025)
-$4.24B
Operating CF (Q4 2025)
$4.29B
CapEx (Q4 2025)
-$3.49B
Free Cash Flow (Q4 2025)
$0.80B
Net Debt Issuance (Q4 2025)
$0.00
Operating CF (Q1 2026)
$1.10B
CapEx (Q1 2026)
-$3.64B
Free Cash Flow (Q1 2026)
-$2.54B
Net Debt Issuance (Q1 2026)
-$1.50B
Operating CF (Q2 2026)
$7.01B
CapEx (Q2 2026)
-$2.56B
Free Cash Flow (Q2 2026)
$4.45B
Net Debt Issuance (Q2 2026)
+$4.67B
Strengths
Concerns
HOLD — Intel presents a mixed picture: the operational turnaround is real with revenue growth accelerating to 25% YoY, gross margins expanding to ~40%, and Q2 2026 FCF hitting +$4.45B. However, the stock trades at a premium 52x forward P/E with extremely high beta of 2.23, and reported earnings remain deeply distorted by one-time portfolio management charges totaling over $12B in Q2 2026 alone. Existing positions can be held given the positive operational inflection, but the elevated valuation and execution risk argue against initiating new long positions until clearer evidence of sustained earnings power emerges. Watch quarterly FCF and gross margin trajectory as the cleanest indicators of operational health.